Venlafaxine original brand?

What is the original brand of Venlafaxine?

The original brand of Venlafaxine is Effexor, which was developed by Wyeth Pharmaceuticals (now part of Pfizer). Effexor is an antidepressant medication that contains the active ingredient venlafaxine hydrochloride. [1] Wyeth Pharmaceuticals first introduced Effexor in the US in 1997. [2]

Who manufactures Venlafaxine now?

Although Effexor is no longer on the market due to patent expiration, venlafaxine is still widely available as a generic drug. It is manufactured by several generic drugmakers, including Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sandoz. [3]

What are the differences between the original brand and generic versions?

According to the FDA, generic versions of venlafaxine must meet the same quality and efficacy standards as the original brand. [4] However, the inactive ingredients, packaging, and manufacturing processes may differ between the original brand and generic versions.

How does patent expiration affect availability and pricing?

The patent for Effexor expired in 2012, making way for generic versions of venlafaxine to enter the market. This competition has led to lower prices for venlafaxine, making it more accessible to patients. [5]

Sources:
[1] Pfizer. (n.d.). Effexor (venlafaxine hydrochloride). Retrieved from https://www.pfizer.com/products/product-detail/effexor
[2] Wyeth Pharmaceuticals. (1997). Effexor (venlafaxine hydrochloride) tablets. Retrieved from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a2c6e1c-5d21-42e9-81ca-4b3d7dcece44
[3] Food and Drug Administration. (n.d.). Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/
[4] Food and Drug Administration. (n.d.). Generic Drugs: The Same Ingredients, Different Brands. Retrieved from https://www.fda.gov/drugs/buying-using-medicine-safely/generic-drugs-same-ingredients-different-brand
[5] The Generic Pharmaceutical Association. (2012). Patent Expiration Spurs Generics Competition. Retrieved from https://www.gphaonline.org/news-events/press-releases/patent-expiration-spurs-generics-competition/